Your session is about to expire
← Back to Search
Short Intervention Program for Suicide Attempt
N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years or older.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 18 months
Awards & highlights
Study Summary
This trial will test a new treatment for people who have recently attempted suicide, in order to learn if it is effective and how it works.
Who is the study for?
This trial is for adults who have attempted suicide within the last 60 days and are willing to provide emergency contact information. Participants must be able to communicate in English, live in New York State during treatment, and not suffer from acute psychiatric instability like psychosis.Check my eligibility
What is being tested?
The study compares a new short intervention program designed for those who've recently attempted suicide against the standard Zero Suicide care. It aims to find an effective, brief, and low-cost therapy that can reduce future suicide attempts.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, side effects may include emotional distress or discomfort during discussions about sensitive topics such as previous suicide attempts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to Suicide Attempt
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Zero Suicide Usual Care + ASSIPExperimental Treatment1 Intervention
Patients in this treatment arm will receive ASSIP brief therapy in addition to being able to access any usual care as recommended by their provider.
ASSIP is a manualized, three-session intervention, delivered either in-person or via telehealth: In Session 1, the therapist guides the patient in telling the story of their attempt. The session is video recorded. In Session 2, the therapist and patient sit side-by-side to view selections of the video, working together to understand the feelings and events that preceded the attempt. The patient is assigned a homework task. In Session 3, the therapist and patient create a summary of the suicide attempt and what led up to it, along with creating a personal safety plan.
Group II: Zero Suicide Usual CareActive Control1 Intervention
In Onondaga County, New York State (NYS) aims to implement a countywide "Zero Suicide Safety Net" of providers who share enhanced protocols for clinical care, staff training, and data collection (improved coding of suicidal behavior). Participating behavioral health systems have agreed to common protocols for clinical care, training, and data collection. Participating providers receive robust training in suicide prevention best practices. Because of the wide participation of mental health facilities in the NYS Office of Mental Health (OMH) Zero Suicide project, most subjects who engage in outpatient treatment will receive that treatment in facilities that are adopting NYS Zero Suicide protocols. Those who do not engage in care will nonetheless experience enhanced transition and follow-up contact from the services from which they are discharged.
Find a Location
Who is running the clinical trial?
State University of New York - Upstate Medical UniversityOTHER
172 Previous Clinical Trials
26,932 Total Patients Enrolled
University of RochesterLead Sponsor
836 Previous Clinical Trials
517,693 Total Patients Enrolled
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,831 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have tried to harm or kill yourself in the last 60 days.I am 18 years old or older.I can communicate in English.You are currently experiencing severe mental health issues that affect your thinking and perception, such as hearing voices or seeing things that are not real.
Research Study Groups:
This trial has the following groups:- Group 1: Zero Suicide Usual Care
- Group 2: Zero Suicide Usual Care + ASSIP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are enrolled in this investigation?
"Affirmative. Clinicaltrials.gov reveals that this experiment, initially posted on October 5th 2020, is actively looking for 400 people to join from 3 distinct medical centres. It was most recently updated on June 11th 2022."
Answered by AI
Is there still room for patient participation in this research endeavor?
"As per the data hosted on clinicaltrials.gov, this medical research is currently receiving applications from participants. It was first published on October 5th 2020 and has been updated as recently as June 11th 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger